The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention

Soren Gantt*, William J Muller

*Corresponding author for this work

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2) infect a large proportion of the world's population. Infection is life-long and can cause periodic mucocutaneous symptoms, but it only rarely causes life-threatening disease among immunocompetent children and adults. However, when HSV infection occurs during the neonatal period, viral replication is poorly controlled and a large proportion of infants die or develop disability even with optimal antiviral therapy. Increasingly, specific differences are being elucidated between the immune system of newborns and those of older children and adults, which predispose to severe infections and reflect the transition from fetal to postnatal life. Studies in healthy individuals of different ages, individuals with primary or acquired immunodeficiencies, and animal models have contributed to our understanding of the mechanisms that control HSV infection and how these may be impaired during the neonatal period. This paper outlines our current understanding of innate and adaptive immunity to HSV infection, immunologic differences in early infancy that may account for the manifestations of neonatal HSV infection, and the potential of interventions to augment neonatal immune protection against HSV disease.

Original languageEnglish (US)
Article number369172
JournalClinical and Developmental Immunology
Volume2013
DOIs
StatePublished - May 13 2013

Fingerprint

Infant, Newborn, Diseases
Infection
Human Herpesvirus 2
Human Herpesvirus 1
Therapeutics
Adaptive Immunity
Infection Control
Innate Immunity
Antiviral Agents
Immune System
Animal Models
Neonatal herpes
Newborn Infant
Population

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{61433696303648958282e491b32d6e34,
title = "The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention",
abstract = "Herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2) infect a large proportion of the world's population. Infection is life-long and can cause periodic mucocutaneous symptoms, but it only rarely causes life-threatening disease among immunocompetent children and adults. However, when HSV infection occurs during the neonatal period, viral replication is poorly controlled and a large proportion of infants die or develop disability even with optimal antiviral therapy. Increasingly, specific differences are being elucidated between the immune system of newborns and those of older children and adults, which predispose to severe infections and reflect the transition from fetal to postnatal life. Studies in healthy individuals of different ages, individuals with primary or acquired immunodeficiencies, and animal models have contributed to our understanding of the mechanisms that control HSV infection and how these may be impaired during the neonatal period. This paper outlines our current understanding of innate and adaptive immunity to HSV infection, immunologic differences in early infancy that may account for the manifestations of neonatal HSV infection, and the potential of interventions to augment neonatal immune protection against HSV disease.",
author = "Soren Gantt and Muller, {William J}",
year = "2013",
month = "5",
day = "13",
doi = "10.1155/2013/369172",
language = "English (US)",
volume = "2013",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Publishing Corporation",

}

The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. / Gantt, Soren; Muller, William J.

In: Clinical and Developmental Immunology, Vol. 2013, 369172, 13.05.2013.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention

AU - Gantt, Soren

AU - Muller, William J

PY - 2013/5/13

Y1 - 2013/5/13

N2 - Herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2) infect a large proportion of the world's population. Infection is life-long and can cause periodic mucocutaneous symptoms, but it only rarely causes life-threatening disease among immunocompetent children and adults. However, when HSV infection occurs during the neonatal period, viral replication is poorly controlled and a large proportion of infants die or develop disability even with optimal antiviral therapy. Increasingly, specific differences are being elucidated between the immune system of newborns and those of older children and adults, which predispose to severe infections and reflect the transition from fetal to postnatal life. Studies in healthy individuals of different ages, individuals with primary or acquired immunodeficiencies, and animal models have contributed to our understanding of the mechanisms that control HSV infection and how these may be impaired during the neonatal period. This paper outlines our current understanding of innate and adaptive immunity to HSV infection, immunologic differences in early infancy that may account for the manifestations of neonatal HSV infection, and the potential of interventions to augment neonatal immune protection against HSV disease.

AB - Herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2) infect a large proportion of the world's population. Infection is life-long and can cause periodic mucocutaneous symptoms, but it only rarely causes life-threatening disease among immunocompetent children and adults. However, when HSV infection occurs during the neonatal period, viral replication is poorly controlled and a large proportion of infants die or develop disability even with optimal antiviral therapy. Increasingly, specific differences are being elucidated between the immune system of newborns and those of older children and adults, which predispose to severe infections and reflect the transition from fetal to postnatal life. Studies in healthy individuals of different ages, individuals with primary or acquired immunodeficiencies, and animal models have contributed to our understanding of the mechanisms that control HSV infection and how these may be impaired during the neonatal period. This paper outlines our current understanding of innate and adaptive immunity to HSV infection, immunologic differences in early infancy that may account for the manifestations of neonatal HSV infection, and the potential of interventions to augment neonatal immune protection against HSV disease.

UR - http://www.scopus.com/inward/record.url?scp=84877261396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877261396&partnerID=8YFLogxK

U2 - 10.1155/2013/369172

DO - 10.1155/2013/369172

M3 - Review article

VL - 2013

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

M1 - 369172

ER -